Status: Not yet recruiting
Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)
To evaluate the safety, tolerability and pharmacokinetics of single and multiple intravenous (IV) infusion of TUL108 in healthy participants.
Participants needed: 72
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Zhuhai United Laboratories Co., Ltd.Updated: Jul 22, 2026Locations: 1
Eligibility criteria
Participants must sign the informed consent form prior to the study, fully under... [+3]
Having a clinically significant severe disease (including but not limited to gas... [+5]